Sandesh Mahatme
CIK 1511034 · CFO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$593.2K
Companies
5
Total Filings
49
Lifetime Open-Market Net
-$50.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRSP | Director | — | $47.55 | — | $0 | 3 | 2026-06-09 |
| VOR | CFO | 0 | $19.39 | $0 | $0 | 2 | 2025-12-09 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 7 | 2022-06-09 |
| SRPT | EVP, CFO & CBO | 30,851 | $15.63 | $482.4K | -$50.71M | 29 | 2020-07-09 |
| FLXN | Director | 4,500 | $24.64 | $110.9K | $0 | 8 | 2020-06-12 |
Recent Filings · Page 4 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-27 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2017-07-21 | SRPT | Mixed | +1,500 | -$1.25M | EDGAR |
| 2017-03-21 | SRPT | Tax (F) | −171 | -$5.2K | EDGAR |
| 2017-03-14 | SRPT | Grant (A) | — | $0 | EDGAR |
| 2016-11-10 | SRPT | Exer (M) | +1,000 | $23.9K | EDGAR |
| 2016-10-19 | SRPT | Mixed | — | -$1.09M | EDGAR |
| 2016-09-21 | SRPT | Grant (A) | +24,430 | $0 | EDGAR |
| 2016-09-02 | SRPT | Tax (F) | −1,013 | -$26.4K | EDGAR |
| 2016-06-22 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2016-06-13 | FLXN | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.